Patents by Inventor Mark C. Faulkner

Mark C. Faulkner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160303061
    Abstract: Compositions for neuroprotection and treatment of neurodegeneration and methods of administering same. In particular, the present invention relates to compositions and methods for preventing or reducing neurodegeneration, such as neurodegeneration caused by Huntington's disease, including administering a daily dose of a composition including an effective amount of creatine hydrochloride to a patient in need thereof. The methods of the present invention allow for lower dosages of supplementation as compared to creatine monohydrate while retaining all of the desired biological effects of creatine supplementation.
    Type: Application
    Filed: April 20, 2016
    Publication date: October 20, 2016
    Applicant: Vireo Systems, Inc.
    Inventors: Mark C. Faulkner, Donald W. Miller, Grant M. Hatch
  • Publication number: 20150306051
    Abstract: The present invention is directed to a third generation form of creatine, specifically a creatine hydrochloride salt, that drives significant improvements in muscle development and recovery due to its enhanced bio-availability, while causing fewer negative side effects compared to previous forms of creatine.
    Type: Application
    Filed: February 24, 2015
    Publication date: October 29, 2015
    Applicant: Vireo Systems, Inc.
    Inventors: Donald W. Miller, Jonathan L. Vennerstrom, Mark C. Faulkner
  • Publication number: 20150164847
    Abstract: A method and composition for treating osteoarthritis including administering an anti-inflammatory agent to a patient, wherein the anti-inflammatory agent is ethyl (?-guanido-methyl) ethanoate. Ethyl (?-guanido-methyl) ethanoate provides a safe, non-toxic anti-inflammatory treatment for osteoarthritis.
    Type: Application
    Filed: December 16, 2014
    Publication date: June 18, 2015
    Applicant: Vireo Systems, Inc.
    Inventors: Mark C. Faulkner, Donald W. Miller, Gary Crawford
  • Patent number: 8962685
    Abstract: The present invention is directed to a third generation form of creatine, specifically a creatine hydrochloride salt, that drives significant improvements in muscle development and recovery due to its enhanced bio-availability, while causing fewer negative side effects compared to previous forms of creatine.
    Type: Grant
    Filed: January 14, 2013
    Date of Patent: February 24, 2015
    Assignees: Vireo Systems, Inc., Board of Regents of the University of Nebraska
    Inventors: Donald W. Miller, Jonathan L. Vennerstrom, Mark C. Faulkner
  • Patent number: 8354450
    Abstract: The present invention is directed to a third generation form of creatine, specifically a creatine hydrochloride salt, that drives significant improvements in muscle development and recovery due to its enhanced bio-availability, while causing fewer negative side effects compared to previous forms of creatine.
    Type: Grant
    Filed: October 21, 2010
    Date of Patent: January 15, 2013
    Assignees: Vireo Systems, Inc., Board of Regents of the University of Nebraska
    Inventors: Donald W. Miller, Jonathan L. Vennerstrom, Mark C. Faulkner
  • Patent number: 8026385
    Abstract: Creatine oral supplementation using creatine hydrochloride salt, that may be added to a liquid or other beverage, or may be also used as an additive to solid oral dosages, or as a supplement, and which may be consumed by the athlete, or other party looking for immediate supplementation of strength, and may be added as a supplement within feed to livestock, in the veterinary area.
    Type: Grant
    Filed: June 3, 2009
    Date of Patent: September 27, 2011
    Assignee: Vireo Systems, Inc.
    Inventors: Donald W. Miller, Jonathan L. Vennerstrom, Mark C. Faulkner
  • Publication number: 20110034421
    Abstract: The present invention is directed to a third generation form of creatine, specifically a creatine hydrochloride salt, that drives significant improvements in muscle development and recovery due to its enhanced bio-availability, while causing fewer negative side effects compared to previous forms of creatine.
    Type: Application
    Filed: October 21, 2010
    Publication date: February 10, 2011
    Inventors: Donald W. Miller, Jonathan L. Vennerstrom, Mark C. Faulkner
  • Patent number: 7608641
    Abstract: Creatine oral supplementation using creatine hydrochloride salt, that may be added to a liquid or other beverage, or may be also used as an additive to solid oral dosages, or as a supplement, and which may be consumed by the athlete, or other party looking for immediate supplementation of strength, and may be added as a supplement within feed to livestock, in the veterinary area.
    Type: Grant
    Filed: May 14, 2004
    Date of Patent: October 27, 2009
    Assignee: Board of Regents of the University of Nebraska
    Inventors: Donald W. Miller, Jonathan L. Vennerstrom, Mark C. Faulkner
  • Publication number: 20090253797
    Abstract: Creatine oral supplementation using creatine hydrochloride salt, that may be added to a liquid or other beverage, or may be also used as an additive to solid oral dosages, or as a supplement, and which may be consumed by the athlete, or other party looking for immediate supplementation of strength, and may be added as a supplement within feed to livestock, in the veterinary area.
    Type: Application
    Filed: June 3, 2009
    Publication date: October 8, 2009
    Inventors: Donald W. Miller, Jonathan L. Vennerstrom, Mark C. Faulkner